Fonte: The Lancet. Unidade: ICB
Assuntos: MICROBIOLOGIA, HORMÔNIOS DO CÓRTEX ADRENAL, COVID-19, ANÓXIA, ESTUDOS RANDOMIZADOS, ANTI-INFLAMATÓRIOS, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALAN, Andrea. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, v. 401, p. 1499-1507, 2023Tradução . . Disponível em: https://doi.org/10.1016/s0140-6736(23)00510-x. Acesso em: 10 out. 2024.APA
Balan, A. (2023). Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401, 1499-1507. doi:10.1016/s0140-6736(23)00510-xNLM
Balan A. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial [Internet]. The Lancet. 2023 ; 401 1499-1507.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/s0140-6736(23)00510-xVancouver
Balan A. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial [Internet]. The Lancet. 2023 ; 401 1499-1507.[citado 2024 out. 10 ] Available from: https://doi.org/10.1016/s0140-6736(23)00510-x
